Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the 'dark genome' that are responsible ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...

In the latest allocation of European funding for cutting-edge research, ETH Zurich scientists have performed exceptionally ...

Prominent companies operating in the global drug discovery services market include: • Charles River Laboratories (US) • ...

Exa-cel could provide benefit before kids develop chronic organ damage ...

ZYUS Life Sciences Corporation (the "Company") , a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, today ...